Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Cardinal Health

Cardinal Health

Cardinal Health is a healthcare and medical company that looks to provide cost-effective healthcare

Cardinal Health is a healthcare and medical company that looks to provide cost-effective healthcare. The company was founded by Robert Walter in 1971, in Dublin, Ohio-based company.

The company looks to help pharmacies, hospitals, and ambulatory care sites in order to provide patient care and reducing costs. The company is interested in improving patient lives at clinics and other healthcare environments. They are known for providing medical products and pharmaceuticals for patient management purposes.


Due to the outbreak of the novel COVID-19 (coronavirus), medical supplies have increased in demand due to shortages in healthcare environments and hospitals. Cardinal Health has worked with suppliers and manufacturers to continue to produce personal protective equipment for healthcare workers. They have worked with groups such as the Health Industry Distributors Association, AdvaMed, and FEMA.


May 14, 2021
Cardinal Health announces redemption of outstanding notes.

Cardinal Health announces that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 3.200% notes due June 2022 that are outstanding as of the early redemption date (aggregate principal amount of $237,558,000) and $262,442,000 in aggregate principal amount of the Company's 2.616% notes due June 2022.

October 2020
Cardinal Health raises a $35,000,000 series B round from Canaan Partners, Casdin Capital, LifeForce Capital, Marc Benioff, McKesson Ventures, Novartis, Section 32 and Threshold Ventures.
January 10, 2019
Cardinal Health acquires Mirixa Corporation.
Cardinal Health was founded by Robert D. Walter and Robert Walter.

Funding Rounds


Further Resources


Cardinal Health acquires Mirixa Corporation


January 10, 2019

Cardinal Health announces redemption of outstanding notes

Cardinal Health


May 14, 2021


Andrea Park
August 23, 2021
Cardinal Health is facing two back-to-back product recalls, each of which was characterized this month as Class I, the FDA's most serious classification, indicating a heightened risk of serious injury or death.
August 12, 2021
TerraPower and Cardinal Health (NYSE: CAH) today announced an agreement that will help advance the next generation of cancer treatment. Under the agreement, the companies will work together to develop and produce Actinium-225 for use in drug development and commercial sales. "Through TerraPower Isotopes®, our team harnesses our focus on nuclear science and innovation and applies it to the health care sector to enable the development of targeted and potentially lifesaving cancer treatments...
Cardinal Health
June 24, 2021
/PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the...
Cardinal Health
June 10, 2021
/PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection - the first and only radiopharmaceutical...
U.S. Renal Care Inc.
June 9, 2021
/PRNewswire/ -- U.S. Renal Care (USRC), a leading provider of dialysis services, announced it has completed administering the second round of mRNA vaccines to...


Golden logo
By using this site, you agree to our Terms & Conditions.